"We are encouraged by USDA-APHIS' broad designation for these traits being developed using our RTDS trait platform. The U.S. has long been a leader in regulatory modernization and this designation is yet another example of how regulatory frameworks have evolved and continue to evolve to support the promise of gene- editing technologies," said Cibus Co-Founder and Interim Chief Executive Officer, Dr. Peter Beetham. "We are especially excited about the prospect of additional modes of action for crop diseases ...

SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that two of its disease resistance trait products under development for canola have been designated as being not regulated by the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA-APHIS) Biotechnology Regulatory Services (BRS). Cibus' Sclerotinia resistance trait i ...